Beta Drugs shareholding pattern

·UnclassifiedChart ›

Who owns itSep 2026 quarter

Promoters58.91%−0.19 pts

Foreign investors (FII)1.37%+0.35 pts

Domestic institutions (DII)6.45%+0.22 pts

Public33.27%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BETA₹1,849.70

Beta Drugs Limited

· Unclassified

₹ CrorePeersTHEJO MACPOWERSAKARSERVOTECHMcap ₹1,875 Cr

Holding % of Total Shares 12 Months Ending	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 27/03/2025	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Promoter & Group	66.73	66.73	66.73	66.73	66.73	66.73	64.90	64.63	59.10	58.91
FII / FPI	1.16	1.15	0.90	0.90	0.90	0.90	1.14	1.16	1.02	1.37
DII	0.16	0.17	0.17	0.17	0.26	0.29	1.90	2.15	6.23	6.45

Latest: 2026-09-30 · 24 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.